215 related articles for article (PubMed ID: 16239560)
1. Moraxella catarrhalis bacterium without endotoxin, a potential vaccine candidate.
Peng D; Hong W; Choudhury BP; Carlson RW; Gu XX
Infect Immun; 2005 Nov; 73(11):7569-77. PubMed ID: 16239560
[TBL] [Abstract][Full Text] [Related]
2. Roles of 3-deoxy-D-manno-2-octulosonic acid transferase from Moraxella catarrhalis in lipooligosaccharide biosynthesis and virulence.
Peng D; Choudhury BP; Petralia RS; Carlson RW; Gu XX
Infect Immun; 2005 Jul; 73(7):4222-30. PubMed ID: 15972513
[TBL] [Abstract][Full Text] [Related]
3. Biological and immunological characteristics of lipooligosaccharide-based conjugate vaccines for serotype C Moraxella catarrhalis.
Yu S; Gu XX
Infect Immun; 2007 Jun; 75(6):2974-80. PubMed ID: 17371852
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis.
Yu S; Gu XX
Infect Immun; 2005 May; 73(5):2790-6. PubMed ID: 15845482
[TBL] [Abstract][Full Text] [Related]
5. Exploration of Moraxella catarrhalis outer membrane proteins, CD and UspA, as new carriers for lipooligosaccharide-based conjugates.
Hu WG; Berry J; Chen J; Gu XX
FEMS Immunol Med Microbiol; 2004 Jun; 41(2):109-15. PubMed ID: 15145454
[TBL] [Abstract][Full Text] [Related]
6. Late acyltransferase genes lpxX and lpxL jointly contribute to the biological activities of Moraxella catarrhalis.
Gao S; Ren D; Peng D; Zhang W; Muszyński A; Carlson RW; Gu XX
J Med Microbiol; 2013 Jun; 62(Pt 6):807-812. PubMed ID: 23475908
[TBL] [Abstract][Full Text] [Related]
7. Role of different moieties from the lipooligosaccharide molecule in biological activities of the Moraxella catarrhalis outer membrane.
Peng D; Hu WG; Choudhury BP; Muszyński A; Carlson RW; Gu XX
FEBS J; 2007 Oct; 274(20):5350-9. PubMed ID: 17892485
[TBL] [Abstract][Full Text] [Related]
8. Mutant lipooligosaccharide-based conjugate vaccine demonstrates a broad-spectrum effectiveness against Moraxella catarrhalis.
Ren D; Yu S; Gao S; Peng D; Petralia RS; Muszynski A; Carlson RW; Robbins JB; Tsai CM; Lim DJ; Gu XX
Vaccine; 2011 Jun; 29(25):4210-7. PubMed ID: 21501641
[TBL] [Abstract][Full Text] [Related]
9. Outer membrane protein UspA1 and lipooligosaccharide are involved in invasion of human epithelial cells by Moraxella catarrhalis.
Spaniol V; Heiniger N; Troller R; Aebi C
Microbes Infect; 2008 Jan; 10(1):3-11. PubMed ID: 18069032
[TBL] [Abstract][Full Text] [Related]
10. Immunological characterisation of truncated lipooligosaccharide-outer membrane protein based conjugate vaccine against Moraxella catarrhalis and nontypeable Haemophilus influenzae.
Singh S; Wilson JC; Cripps AW; Massa H; Ozberk V; Grice ID; Peak IR
Vaccine; 2020 Jan; 38(2):309-317. PubMed ID: 31668366
[TBL] [Abstract][Full Text] [Related]
11. Functional characteristics of a protective monoclonal antibody against serotype A and C lipooligosaccharides from Moraxella catarrhalis.
Hu WG; Chen J; McMichael JC; Gu XX
Infect Immun; 2001 Mar; 69(3):1358-63. PubMed ID: 11179299
[TBL] [Abstract][Full Text] [Related]
12. Immunoinformatics Identifies a Lactoferrin Binding Protein A Peptide as a Promising Vaccine With a Global Protective Prospective Against Moraxella catarrhalis.
Yassin GM; Amin MA; Attia AS
J Infect Dis; 2016 Jun; 213(12):1938-45. PubMed ID: 26908723
[TBL] [Abstract][Full Text] [Related]
13. Current progress of adhesins as vaccine candidates for Moraxella catarrhalis.
Tan TT; Riesbeck K
Expert Rev Vaccines; 2007 Dec; 6(6):949-56. PubMed ID: 18377357
[TBL] [Abstract][Full Text] [Related]
14. Virulence factors of Moraxella catarrhalis outer membrane vesicles are major targets for cross-reactive antibodies and have adapted during evolution.
Augustyniak D; Seredyński R; McClean S; Roszkowiak J; Roszniowski B; Smith DL; Drulis-Kawa Z; Mackiewicz P
Sci Rep; 2018 Mar; 8(1):4955. PubMed ID: 29563531
[TBL] [Abstract][Full Text] [Related]
15. Intranasal vaccination with recombinant outer membrane protein CD and adamantylamide dipeptide as the mucosal adjuvant enhances pulmonary clearance of Moraxella catarrhalis in an experimental murine model.
Becker PD; Bertot GM; Souss D; Ebensen T; Guzmán CA; Grinstein S
Infect Immun; 2007 Apr; 75(4):1778-84. PubMed ID: 17101651
[TBL] [Abstract][Full Text] [Related]
16. Immunization with the truncated adhesin moraxella catarrhalis immunoglobulin D-binding protein (MID764-913) is protective against M. catarrhalis in a mouse model of pulmonary clearance.
Forsgren A; Brant M; Riesbeck K
J Infect Dis; 2004 Jul; 190(2):352-5. PubMed ID: 15216472
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis.
Gu XX; Chen J; Barenkamp SJ; Robbins JB; Tsai CM; Lim DJ; Battey J
Infect Immun; 1998 May; 66(5):1891-7. PubMed ID: 9573066
[TBL] [Abstract][Full Text] [Related]
18. Moraxella catarrhalis: from interactions with the host immune system to vaccine development.
Su YC; Singh B; Riesbeck K
Future Microbiol; 2012 Sep; 7(9):1073-100. PubMed ID: 22953708
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a cluster of three glycosyltransferase enzymes essential for Moraxella catarrhalis lipooligosaccharide assembly.
Edwards KJ; Allen S; Gibson BW; Campagnari AA
J Bacteriol; 2005 May; 187(9):2939-47. PubMed ID: 15838019
[TBL] [Abstract][Full Text] [Related]
20. A mutation affecting expression of a major outer membrane protein of Moraxella catarrhalis alters serum resistance and survival in vivo.
Helminen ME; Maciver I; Paris M; Latimer JL; Lumbley SL; Cope LD; McCracken GH; Hansen EJ
J Infect Dis; 1993 Nov; 168(5):1194-201. PubMed ID: 8228353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
